Table 1.
The basic characteristic of stroke survivors between the male Egyptian versus Chinese patients with or without sarcopenia.
| Variables | Stroke Survivors in EgyptianPatients | Stroke Survivors in Chinese Patients | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Total, n (%) | Without Sarcopenic | With Sarcopenic | p-Value | Total | Without Sarcopenic | With Sarcopenic | p-Value | ||
| Gender | 200 | 195 | |||||||
| Males | 125(62.50) | 99 | 26 | 125(64.10) | 98 | 27 | |||
| Females | 75(37.50) | 70(35.90) | |||||||
| Age mean ± SD | 55.54 ± 13.1 | 51.6 ± 11.11 | 67.1 ± 7.30 | 0.000 c | 52.8 ± 15.15 | 53.09 ± 15.07 | 53.40 ± 15.25 | 0.925 c | |
| Stroke type, n (%) | |||||||||
| Ischemic | 121(60.50) | 56(56.60) | 18(69.20) | 0.242 a | 84(43.10) | 42(42.9) | 15(55.6) | 0.241 a | |
| Hemorrhagic | 79(39.50) | 43(43.40) | 8(30.80) | 111(56.9) | 56(57.1) | 12(44.4) | |||
| Affected side, n (%) | |||||||||
| Right side Left side |
102(51) 98(49) |
42(42.40) 57(57.60) |
18(69.20) 8(30.80) |
0.015 a | 66(32.80) 129(66.20) |
39(39.80) 59(60.20) |
9(33.30) 18(66.70) |
0.541 a | |
| Smoking n (%) | |||||||||
| No | 110(55) | 27(27.30) | 9(34.60) | 0.462 a | 120(61.50) | 48(49) | 20(70.4) | 0.020 a | |
| Yes | 90(45) | 72(72.70) | 17(65.40) | 75(38.50) | 50(51) | 7(25.9) | |||
| Drinking history, n (%) | |||||||||
| No | 200(100%) | 99(100) | 26(100) | ------ | 99(50.70) | 35(35.70) | 13(48.1) | 0.240 a | |
| Yes | 0(0.0) | 0(0.0) | 0(0.0) | 96(49.20) | 63(64.30) | 14(51.90) | |||
| HTN, n (%) | |||||||||
| No | 29(14.50) | 17(17.20) | 0(0.0) | 0.023 a | 49(24.70) | 20(20.40) | 5(18.50) | 0845 a | |
| Yes | 171(85.5%) | 82(82.8%) | 26(100) | 146(73.7%) | 78(79.20) | 22(81.5) | |||
| DM, n (%) | |||||||||
| No | 118(59) | 67(67.70) | 12(50) | 0.095 a | 24(12.30) | 13(13.30) | 3(11.10) | 0.767 a | |
| Yes | 82(41) | 32(32.30) | 12(50) | 171(87.70) | 85(86.70) | 24(88.90) | |||
| IHD, n (%) | |||||||||
| No | 142(71) | 81(81.80) | 12(46.20) | 0.000 a | 165(84.60) | 79(80.60) | 22(81.50) | 0.919 a | |
| Yes | 58(29) | 18(18.20) | 14(53.80) | 30(15.40) | 19(19.40) | 5(18.50) | |||
| Performed conventional rehabilitation in the early phase, n (%) | |||||||||
| No | 116(58) | 53(53.50) | 15(57.70) | 0.705 a | 65(33.30) | 35(35.70) | 14(51.90) | 0.128 a | |
| Yes | 84(42) | 46(46.50) | 11(42.30) | 130(66.70) | 63(64.30) | 13(48.10) | |||
| Dyslipidemia | |||||||||
| No | 140(70) | 76(76.80) | 12(46.2) | 0.002 a | 72(36.90) | 66(67.0) | 11(40.70) | 0.012 a | |
| Yes | 60(30) | 23(23.20) | 14(53.8) | 123(63.10) | 32(32.70) | 16(59.0) | |||
| Mini Nutritional Assessment-Short Form(MNA-SF) | |||||||||
| Malnutrition | 59(29.50) | 12(12.10) | 17(65.40) | 0.000 a | 65(33.30) | 24(24.50) | 10(37) | 0.297 a | |
| Risky | 59(29.50) | 33(32.30) | 4(19.20) | 45(23.07) | 22(22.40) | 7(25.9) | |||
| Normal | 82(41.0) | 55(55.60) | 4(15.40) | 85(43.50) | 52(53.10) | 10(37) | |||
| FIM motor, median, IQR | |||||||||
| FIM motor | 48(45–72) | 46(56–75) | 38(41–59) | 0.000 b | 55(40–66) | 52(48–70) | 52(40–65) | 0.040 b | |
| FIM cognitive | 31(28–33) | 32(30–34) | 24(23–29) | 0.000 b | 31(29–33) | 31(30–33) | 20(28–33) | 0.207 b | |
| FIM total | 81(72–105) | 98(87–108) | 51(65–89) | 0.000 b | 62(69–100) | 61(77–101) | 60(67–96) | 0.037 b | |
| Modified Rankin scale | 2(1–4) | 2(1–3) | 4(2–5) | 0.000 b | 4(3–4) | 4(3–4) | 4(3–4) | 0.288 b | |
| Time from stroke onset per month, median, IQR | 57(34–43) | 47(36–44) | 35(35–43) | 0.400 b | 49(35–44) | 36(36–45) | 30(38–46) | 0.153 b | |
| Weight/kg mean ± SD | 71.62 ± 11.0 | 77.01 ± 8.50 | 63.9 ± 8.70 | 0.000 c | 69.9 ± 12.12 | 74.88 ± 10.10 | 76.92 ± 11.07 | 0.365 c | |
| Height/m | 167.60 ± 8.1 | 172.03 ± 5.38 | 171.79 ± 5.60 | 0.779 c | 170.0 ± 7.26 | 173.76 ± 3.7 | 176.4 ± 2.6 | 0.001 c | |
| BMI (kg/m2) | 25.3 ± 4.20 | 26.33 ± 3.30 | 21.01 ± 2.80 | 0.000 c | 24.0 ± 3.04 | 24.7 ± 2.9 | 24.3 ± 3.40 | 0.902 c | |
| SMI (kg/m2) | 7.1 ± 1.50 | 8.3 ± 0.822 | 6.2 ± 0.45 | 0.000 c | 7.19 ± 1.24 | 7.9 ± 0.51 | 6.13 ± 0.75 | 0.000 c | |
| HG strength/kg | 23.32 ± 17.7 | 33.9 ± 17.27 | 14.8 ± 13.10 | 0.000 c | 29.2 ± 9.34 | 31.86 ± 8.9 | 28.88 ± 0.02 | 0.129 c | |
| Calf affected | 36.02 ± 4.7 | 37.96 ± 2.90 | 31.23 ± 2.17 | 0.000 c | 35.7 ± 3.40 | 37.84 ± 2.2 | 32.68 ± 4.30 | 0.000 c | |
| Calf unaffected | 36.3 ± 3.9 | 38.21 ± 2.80 | 31.53 ± 2.10 | 0.000 c | 35.56 ± 3.40 | 37.65 ± 1.9 | 31.18 ± 2.98 | 0.000 c | |
| CCI, median IQR | 4(3–5) | 4(3–4) | 5(4–6) | 0.000 b | 4(3–5) | 3(3–5) | 6(3–5) | 0.177 b | |
| SARC-F, median, IQR | 4(0–8) | 2(0–4) | 8(5–10) | 0.000 b | 4(2–8) | 4(2–8) | 8(2–8) | 0.343 b | |
| NIHSS, median, IQR | 5(3–9) | 4(3–6) | 8(6–14) | 0.000 b | 6(4–8) | 6(4–8) | 10(4–9) | 0.961 b | |
DM: diabetes mellitus, HTN: hypertension, IHD: ischemic heart disease, BMI: body mass index, SMI: skeletal muscle index, FIM: functional independence measure, NIHSS: National Institute of Health Stroke Scale, CCI: Carlson comorbidity index, a—Chi-square test, b—Manne–Whitney U test,c—t-test.